Astrasana Holding AG

Astrasana Group receives Swissmedic license for the cultivation of medical cannabis

Zurich (ots) - The Astrasana Group is pleased to announce that its subsidiary, Astrasana Pharma AG, has been granted the official cultivation license for medical cannabis by Swissmedic. This authorization permits the controlled cultivation of cannabis plants with a THC content above 1% and marks an important milestone in the expansion of the Group's pharmaceutical ...

Japan’s CBD Industry Recieves First Investments From Publicly Listed Companies Following

Astrasana and Clever Leaves Partner to Establish International Supply Agreement For Medical Cannabis Extracts in Czech Republic and Switzerland